Biocept Inc. (BIOCQ) — Financial Flexibility Index

Latest as of June 2023: -0.14x

Biocept Inc. (BIOCQ) has a Financial Flexibility Index of -0.14x as of June 2023. Free cash flow of $-2.99 Million (operating CF $-3.09 Million minus capex $97.00K) represents 0% of total liabilities ($21.81 Million). Check Biocept Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

-0.14x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-2.99 Million
Operating CF − Capex

Total Liabilities

$21.81 Million
USD

Capital Expenditures

$97.00K
USD

Biocept Inc. Financial Flexibility Index (2019–2022)

Historical Financial Flexibility Index trend for Biocept Inc. across 4 annual periods. For the full cash flow conversion analysis, see Biocept Inc. cash conversion from operations.

Annual Financial Flexibility Index for Biocept Inc. (2019–2022)

Year-by-year free cash flow to debt coverage for Biocept Inc.. Explore BIOCQ cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2022 -0.57x $-12.48 Million $-13.29 Million $22.01 Million ▼ -347.2%
2021 0.23x $5.26 Million $3.69 Million $22.94 Million ▲ +128.8%
2020 -0.80x $-18.92 Million $-19.79 Million $23.76 Million ▲ +76.7%
2019 -3.42x $-22.31 Million $-23.05 Million $6.53 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities